To evaluate the long-term efficacy of verteporfin photodynamic therapy (PDT) as the primary treatment for symptomatic circumscribed choroidal hemangioma (CCH).

Blasi, M. A., Tiberti, A. C., Scupola, A., Balestrazzi, A., Colangelo, E., Valente, P., Balestrazzi, E., Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes, <<OPHTHALMOLOGY>>, 2010; 117 (8): 1630-1637. [doi:10.1016/j.ophtha.2009.12.033] [http://hdl.handle.net/10807/43474]

Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes

Blasi, Maria Antonietta;Tiberti, Alessandra Cristiana;Scupola, Andrea;Valente, Paola;Balestrazzi, Emilio
2010

Abstract

To evaluate the long-term efficacy of verteporfin photodynamic therapy (PDT) as the primary treatment for symptomatic circumscribed choroidal hemangioma (CCH).
2010
Inglese
Blasi, M. A., Tiberti, A. C., Scupola, A., Balestrazzi, A., Colangelo, E., Valente, P., Balestrazzi, E., Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes, <<OPHTHALMOLOGY>>, 2010; 117 (8): 1630-1637. [doi:10.1016/j.ophtha.2009.12.033] [http://hdl.handle.net/10807/43474]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/43474
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact